![Chad Winters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 518 941 $ as of 31/07/2026
Chad R.
Winters is currently Chief Accounting Officer & VP-Finance at West Pharmaceutical Services, Inc. since 2024.
Former positions include Director at La Causa, Inc. and Controller, Senior VP-Finance & Accounting at Amneal Intermediate, Inc. Education includes an undergraduate degree from Villanova University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/04/2026 | 1,522 ( 0% ) | 518 941 $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
| WEST PHARMACEUTICAL SERVICES, INC. | Comptroller/Controller/Auditor | 01/10/2019 |
| Companies | Position | End |
|---|---|---|
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Comptroller/Controller/Auditor | - |
La Causa, Inc.
 La Causa, Inc. Services to the Health IndustryHealth Services Provides social services | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
West Pharmaceutical Services, Inc.
 West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
La Causa, Inc.
La Causa, Inc. Services to the Health IndustryHealth Services Provides social services | Health Services |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
